Xueya Zhou

Xueya Zhou

Auto-generated profile, based on publicly available information

Xueya Zhou

MOE Key Laboratory of Bioinformatics, Bioinformatics Division and Center for Synthetic and Systems Biology, TNLIST/Department of Automation, Tsinghua University, Beijing, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2017 in Genetic Epidemiology
Verified
Journal Article
Open access
PDF file
TMTimothy Shin Heng Mak
Timothy Shin Heng Mak
RPRobert Milan Porsch
Robert Milan Porsch
SCShing Wan Choi
Shing Wan Choi
XZXueya Zhou
Xueya Zhou
PSPak Sham
Pak Sham
Polygenic scores (PGS) summarize the genetic contribution of a person's genotype to a disease or phenotype. They can be used to group participants into different risk categories for diseases, and are also used as covariates in epidemiological analyses. A number of possible ways of calculating PGS have been proposed, and recently there is much interest in methods that incorporate information available in published summary statistics. As there is no inherent information on linkage disequilibrium (LD) in summary statistics, a pertinent question is how we can use LD information available elsewhere to supplement such analyses. To answer this question, we propose a method for constructing PGS using summary statistics and a reference panel in a penalized regression framework, which we call lassosum. We also propose a general method for choosing the value of the tuning parameter in the absence of validation data. In our simulations, we showed that pseudovalidation often resulted in prediction accuracy that is comparable to using a dataset with validation phenotype and was clearly superior to the conservative option of setting the tuning parameter of lassosum to its lowest value. We also showed that lassosum achieved better prediction accuracy than simple clumping and P‐value thresholding in almost all scenarios. It was also substantially faster and more accurate than the recently proposed LDpred.

15 May 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NKNorihiro Kato
Norihiro Kato
FTFumihiko Takeuchi
Fumihiko Takeuchi
YTYasuharu Tabara
Yasuharu Tabara
TKTanika N Kelly
Tanika N Kelly
MGMin Jin Go
Min Jin Go
JHJiang He
Jiang He

21 September 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BIBIOS-consortium
BIOS-consortium
NKNorihiro Kato
Norihiro Kato
CGCARDIo GRAMplusCD
CARDIo GRAMplusCD
LSLifeLines Cohort Study
LifeLines Cohort Study
TCThe InterAct Consortium
The InterAct Consortium
JCJohn C Chambers
John C Chambers

23 August 2019 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
PFPamela Feliciano
Pamela Feliciano
XZXueya Zhou
Xueya Zhou
IAIrina Astrovskaya
Irina Astrovskaya
TTTychele N Turner
Tychele N Turner
TWTianyun Wang
Tianyun Wang
WCWendy K. Chung
Wendy K. Chung
Autism spectrum disorder (ASD) is a genetically heterogeneous condition, caused by a combination of rare de novo and inherited variants as well as common variants in at least several hundred genes. However, significantly larger sample sizes are needed to identify the complete set of genetic risk factors. We conducted a pilot study for SPARK (SPARKForAutism.org) of 457 families with ASD, all consented online. Whole exome sequencing (WES) and genotyping data were generated for each family using DNA from saliva. We identified variants in genes and loci that are clinically recognized causes or significant contributors to ASD in 10.4% of families without previous genetic findings. In addition, we identified variants that are possibly associated with ASD in an additional 3.4% of families. A meta-analysis using the TADA framework at a false discovery rate (FDR) of 0.1 provides statistical support for 26 ASD risk genes. While most of these genes are already known ASD risk genes,BRSK2has the strongest statistical support and reaches genome-wide significance as a risk gene for ASD (p-value = 2.3e−06). Future studies leveraging the thousands of individuals with ASD who have enrolled in SPARK are likely to further clarify the genetic risk factors associated with ASD as well as allow accelerate ASD research that incorporates genetic etiology.

1 September 2013 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
NFNora Franceschini
Nora Franceschini
EFErvin Fox
Ervin Fox
ZZZhaogong Zhang
Zhaogong Zhang
TETodd L. Edwards
Todd L. Edwards
MNMichael A. Nalls
Michael A. Nalls
XZXiaofeng Zhu
Xiaofeng Zhu

26 May 2014 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
WWWanqing Wen
Wanqing Wen
WZWei Zheng
Wei Zheng
YOYukinori Okada
Yukinori Okada
FTFumihiko Takeuchi
Fumihiko Takeuchi
YTYasuharu Tabara
Yasuharu Tabara
TTToshihiro Tanaka
Toshihiro Tanaka
Recent genetic association studies have identified 55 genetic loci associated with obesity or body mass index (BMI). The vast majority, 51 loci, however, were identified in European-ancestry populations. We conducted a meta-analysis of associations between BMI and ∼2.5 million genotyped or imputed single nucleotide polymorphisms among 86 757 individuals of Asian ancestry, followed by in silico and de novo replication among 7488–47 352 additional Asian-ancestry individuals. We identified four novel BMI-associated loci near the KCNQ1 (rs2237892, P = 9.29 × 10−13), ALDH2/MYL2 (rs671, P = 3.40 × 10−11; rs12229654, P = 4.56 × 10−9), ITIH4 (rs2535633, P = 1.77 × 10−10) and NT5C2 (rs11191580, P = 3.83 × 10−8) genes. The association of BMI with rs2237892, rs671 and rs12229654 was significantly stronger among men than among women. Of the 51 BMI-associated loci initially identified in European-ancestry populations, we confirmed eight loci at the genome-wide significance level (P < 5.0 × 10−8) and an additional 14 at P < 1.0 × 10−3 with the same direction of effect as reported previously. Findings from this analysis expand our knowledge of the genetic basis of obesity.